Recombinant albumin produced by baker’s yeast (Saccharomyces cerevisiae) is more environmentally friendly compared to traditional sources like human plasma or bovine serum for several reasons. Microbial systems such as yeast can be cultured in large bioreactors, using renewable resources like simple sugars for their growth. This approach can be scaled up or down with relative ease, making it a more sustainable option compared to relying on human donors or livestock, which require more extensive land, water, and feed resources. This also addresses concerns related to animal welfare and the environmental impact of livestock farming, such as greenhouse gas emissions, land degradation, and water use. Traditional methods of albumin extraction from blood or serum pose significant environmental hazards due to the biohazardous waste produced. In contrast, recombinant production from yeast in contained bioreactor systems reduces environmental contamination. The waste yeast is also rich in nutrients and completely free from antibiotics, so it even has value as a fertiliser. Modern yeast strains for recombinant albumin production can now be genetically optimised by QTL technology to produce high yields of albumin with fewer resources while generating less waste. For example, yeast strains can be selected to grow at higher temperatures, thereby reducing the amount of cooling energy and water required and providing a more efficient production process. This optimisation can lead to lower energy and resource consumption per unit of albumin produced.